Focus:
Royal Philips has introduced a comprehensive and open platform called IntelliSpace Discovery 3.0 to enable development of artificial intelligence assets and their deployment in radiology to help teams carry out...
Teampac has appointed Carl Fagerudd to the position of sales director, as the company continues to develop its offering for healthcare products and to strengthen its solution-oriented customer care.
A team of US researchers has found that artificial intelligence (AI) can improve the ability of brain imaging to detect Alzheimer’s earlier.
Rutgers University researchers have developed a screening tool for detecting obstructive sleep apnoea (OSA) in epilepsy patients whose sleep disorders can augment their seizures.
Researchers at Lund University in Sweden have led an international study for a new brain imaging method designed to enable diagnosis of Alzheimer’s disease.
Researchers from University College London (UCL) and University College London Hospitals (UCLH) have devised a simple blood test that can identify early physiological changes caused by Huntington’s disease.
In the last few days, Otsuka announced it has entered into a collaboration with Magellan Health to distribute its Abilify MyCite digital pill—a unique antipsychotic that has a Proteus Digital...
Successful migraine treatments still elude the medical industry despite the World Health Organisation classifying chronic migraine as more disabling than blindness, paraplegia, angina or rheumatoid arthritis. US-based company electroCore claims...
Researchers from the University of Alabama at Birmingham (UAB) in the US have developed an algorithm that can automatically detect focal epileptic seizures.
The Australian Government has given a grant to the Sydney Neuroimaging Analysis Centre (SNAC) for the development of new medical imaging techniques based on artificial intelligence.
